Question

I am a breastfeeding mother and i want to know if it is safe to use 14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester? Is 14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester safe for nursing mother and child? Does 14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester extracts into breast milk? Does 14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester has any long term or short term side effects on infants? Can 14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester influence milk supply or can 14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester decrease milk supply in lactating mothers?

14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester lactation summary

14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester usage has low risk in breastfeeding
  • DrLact safety Score for 14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester is 3 out of 8 which is considered Low Risk as per our analyses.
  • A safety Score of 3 indicates that usage of 14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester may cause some minor side effects in breastfed baby.
  • Our study of different scientific research indicates that 14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester may cause moderate to no side effects in lactating mother.
  • Most of scientific studies and research papers declaring usage of 14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • While using 14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About 14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester usage in lactation

Used in the treatment to improve the brain circulation. It is possible a nonessential therapy. Check-up for vomiting, irritability or insomnia.

Alternate Drugs for Peripheral Vasodilators. ATC C04

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.